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Occult Cushing's Syndrome Presenting with Osteoporosis 
M. Kleerekoper, MD,* Sudhaker D. Rao, MB, BS,* B. Frame, MD,* R.D. LaRocque, MD, ' 
T. Feigelman, MD,* V. Matkovic, MD, PhD, and L. V. Avioli, MD** * 
Osteoporosis is a frequent complication both of endo-
genous hypercortisolism and of long-term treatment with 
corticosteroids, but only rarely is it the major clinical 
feature with the more characteristic features absent or 
minimally present. In the two patients presented, hyper-
cortisolism was uncovered only during routine evaluation 
of osteoporosis. This presentation is probably due to slow 
progression of the disease and is often associated with so-
called black adenoma of the adrenal gland. Secondary 
causes should be sought in all patients with seemingly 
"senile" or "postmenopausal" osteoporosis. 
Accelerated bone loss with symptomatic vertebral com-
pression or long bone fractures is a we 11-recognized and 
frequent complication of long-term corticosteroid therapy 
(1). In endogenous hypercortisolism (2), osteoporosis is 
usually detected after the diagnosis has been established 
in patients with more obvious manifestations, such as 
amenorrhea, weight gain, or hirsutism. We report two 
patients who were referred primarily for evaluation of 
osteoporosis. The usual clinical features of hypercortisol-
ism were absent, and the diagnosis was established only 
when the urine-free Cortisol was measured during the 
evaluation of osteoporosis. 
Case Reports 
Case 1 
A 52-year-old white woman was referred to Henry Ford Hospital 
for evaluation of osteoporosis in August 1976. In 1954, she had 
developed ulcerative colitis during the eighth month of her 
second pregnancy, fo l lowed by postpartum sept icemia and 
pyoderma gangrenosum. Between 1954 and 1961, the ulcerative 
colitis responded poorly to azulfidine. There were several epi-
sodes of acute arthritis of both hands. Corticosteroid therapy was 
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tried but quickly discontinued because of psychotic episodes. In 
1961, a total colectomy led to complete resolution of both gas-
trointestinal and arthritic symptoms. In 1963, after a single epi-
sode of right ureteric colic, she passed a stone spontaneously; it 
was not analysed. In 1971, hypertension was noted for the first 
time. In May 1976, a traumatic fracture of the right inferior pubic 
ramus healed wel l , but the pelvis and lumbar spine were reported 
as "demineralized" on x-rays. She had felt vaguely unwell for the 
past several years with nonspecific weakness, lethargy, arthralgias 
and easy bruising. She denied recent weight gain. The menopause 
had occurred five years earlier, and she had taken no estrogen 
replacement. 
Physical examinat ion revealed moderate obesity, sl ight ly 
plethoric face, bruises over both shins, slight wasting of the left 
thenar eminence and dorsum of both wrists, and an ileostomy. 
Blood pressure was 180/105 mmHg, height 5'3", weight 142y2 lbs. 
The x-rays revealed generalized osteoporosis with healed frac-
tures o f the right superior and inferior pubic rami without abun-
dant callus. Bone mineral content by photon absorptiometry was 
0.513 gm/cm at the proximal site and 0.310 gm/cm at the distal 
site ( -3 .50 SD and -5 .02 SD, respectively) below the normal 
mean value adjusted for age, sex, and race). Serum calcium, 
phosphorus, total prote in, a lkal ine phospatase, BUN and 
creatinine were all within normal limits. Thyroid function tests 
were normal . A transi l iac crest bone biopsy after double 
tetracycline labeling showed a moderate decrease in the osteoid 
surface wth a significant reduction in the osteoblast surface. Total 
resorption surface, mineral appositional rate, and bone formation 
rate were within normal limits. Urine-free Cortisol excretion ob-
tained as part of the routine workup for osteoporosis was 755 
^ig/24 hrs. Because of this unexpected finding, the patient was 
asked to bring old photographs of herself; these indicated evolv-
ing, mild Cushing's syndrome. Plasma Cortisol was 15.5 /xg/dl at 
8 a.m. and 16.2 ju.g/dl at 4 p.m., indicating loss of normal diurnal 
variation. Two mg of dexamethasone failed to suppress the urine-
132 
Cushing's Syndrome with Osteoporosis 
free Cortisol excretion (Table 1). ^ "1 iodocholesterol scan revealed 
an adenoma of the right adrenal gland with contralateral suppres-
sion of the left adrenal gland. The right adrenal gland was 
removed; it weighed 8.5 gms and contained a cortical adenoma 
with black pigment—the so-called black adenoma ofthe adrenal 
(3). There was no evidence of micronodular hyperplasia. She 
required treatement with ACTH for ten months before normal 
adrenal function was restored. A compression fracture o f the L-1 
vertebra occurred one month after surgery, but she was subse-
quently free of backache. 
When last seen in January 1980, she had lost the Cushingoid 
appearance. Her weight was 133 lbs ( - 9 lbs), height 5 '2" (-1"), 
and there was no significant change in her bone mineral content. 
Her blood pressure was normal without any antihypertensive 
therapy. Urine calcium excretion declined progressively (Table I) 
without further stone episodes. 
Case 2 
A 62-year-old white man was referred to The Jewish Hospital of 
St. Louis for evaluation of osteopenia in November 1975. During 
the previous two years he had sustained several compression 
fractures of the vertebrae with 6y2"loss in height, several fractures 
of the ribs, and a pathologic fracture of the right inferior pubic 
ramus and right acetabulum. Ureteric colic due to stones had 
occurred in 1951, and again in 1961, when a nephrostomy was 
performed for left hydronephrosis. The stone was composed of 
calcium oxalate. He did well on a low calcium and oxalate diet, 
except for one further episode of ureteric colic in 1974. His father 
and sister also had kidney stones. 
On physical examination, none of the usual features of hypercor-
tisolism were present, except for thin and atrophic skin and 
several purpuric lesions on both hands. Several angiomata were 
seen on the torso, and the extremities were thin with muscle 
wasting. Blood pressure was 140/80 mmHg. 
X-rays confirmed the old pelvic fractures, compression fractures 
ofthe Sth and 11th thoracic and 4th lumbar vertebrae and several 
rib fractures. Serum calcium, phosphorus, alkaline phosphatase, 
total protein, BUN, creatinine, fasting blood sugar were all within 
normal limits. Urine calcium excretion was 333 mg/24 hrs. 
Immunoreactive parathyroid hormone level was 6 /uLEq/ml (nor-
mal -8 /aLEq/ml). Plasma Cortisol was 14.7 /xg/dl at 8 a.m. and 
2.3 /ag/dl at 4 p.m., which was a normal diurnal change; but 
urine-free Cortisol excretion was 170 and 166 /Ag/24 hrs. After 
2 mg of dexamethasone, urine-free Cortisol fell to 64 /i.g/24 hrs, 
and after 8 mg to 32 fi.g/24 hrs (Table II). A transiliac crest bone 
biopsy showed increased numbers of osteoblasts and osteoclasts; 
tetracycline uptake was depressed, suggesting diminished new 
bone formation. 
Calciferol 1.25 mg twice weekly and hydrochlorothiazide 50 mg 
twice daily were started. Later, because of hypercalcemia, the 
doses were reduced to 1.25 mg weekly and 50 mg three times 
weekly, respectively. A repeat dexamethasone suppression test 
confirmed the previous findings, and plasma ACTH was raised 
(Table II). Because he was a poor operative risk, he was treated 
with ortho-para DDD (mitotane) 4.5 gms/day for six weeks. The 
plasma Cortisol and urine-free Cortisol levels remained elevated. 
ACTH was 82 pg/ml in the morning and 220 pg/ml in the 
afternoon. The visual fields were normal. 
In September 1976, he was referred to Berkeley California for 
heavy part ic le i r radiat ion and was also started on Elipten 
(a-glutethimide) 250 mg three times a day. After this treatment, 
his bone pain decreased, he felt better, and was able to move 
about more easily. Over the next six months, plasma Cortisol 
decreased to 9 fLg/d\, urine-free Cortisol to 68 /xg/24 hrs, and 
urine calcium 111 mg/24 hrs. There was no recurrence of fractures 
or kidney stones. 
Laboratory Methods 
Serum calcium, phosphorus, total protein, alkaline phos-
phatase, BUN and creatinine were measured by routine 
autoanalyser methods. Urine calcium was measured by 
atomic absorption spectrometry (normal OOO mg/24 hrs, 
for men and <250 mg/24 hrs for women on regular home 
diet). In Case 1, plasma Cortisol and urine-free Cortisol were 
measured by radioimmunoassay (RIA) using a commer-
cially available kit (normal ranges for plasma 7-25 ^tg/dl 
(a.m.) and 7-9 jug/dl (p.m.) and for urine 20-90 p.g/24 hrs). 
Plasma ACTH was measured by RIA (Sera Inc, Columbus, 
Oh io , normal range 15-80 pg/ml) . Urine 17 hydroxy 
steroids were measured by the Porter-Silber method (nor-
mal range 4-12 mg/24 hrs). The investigations in Case 2 
were performed at different institutions, but the normal 
ranges were about the same as in Case 1. 
Discussion 
The usual clinical features of hypercortisolism (both ex-
ogenous and endogenous) include marked obesity, moon 
face, pinkish striae, hypertension, diabetes, and hirsutism. 
Although common, osteoporosis receives little attention; it 
can occur in all forms of corticosteroid excess, including 
the ectopic ACTH syndrome (4). 
The effects of hypercortisolism on bone and mineral me-
tabolism are varied both in scope and severity. They in-
clude growth retardation in children (5), osteoporosis in 
adolescents and adults (2,6), w i th d isproport ionate ly 
greater trabecular bone loss (7), and aseptic necrosis of the 
femoral or humeral head in adults (8). About 20% of 
patients with endogenous hypercortisolism have nephro-
lithiasis (9,10), and they usually have osteoporosis as well 
(10). Radiographic nephrocalcinosis is rare, but histologic 
nephrocalcinosis is more common than nephrolithiasis (9). 
For unknown reasons nephrolithiasis is rare in exogenous 
hypercortisolism. 
The adverse effects of corticosteroid excess on bone and 
mineral metabolism are mediated by several mechanisms, 
including decreased intestinal calcium absorption leading 
to secondary hyperparathyroidism (11), decreased renal 
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TABLE I 
Endocrine Studies 
Case 1 
Plasma Urine 
Cortisol ACTH Free Cortisol 17-OHCS Ca 
(ftg/dl) (pg/ml) (Mg/24hr) (mg/24 hr) (mg/24 hr) 
a.m. p.m. 
Control 12-13-76 24.1 294 
Control 2-2-77 15.5 755 229 
Control 3-3-77 18.5 
Control 3-11-77 19.3 49 
6 hr infusion 3-11-77 21.5 
Control 4-2-77 18.3 590 
Control 4-3-77 18.4 53 655 16.4 
Dexame* 2 mg/day 4-4-77 17.5 530 16.3 
Dexame 2 mg/day 4-5-77 19.4 63 624 17.8 
Dexame 8 mg/day 4-6-77 16.2 479 17.9 
Dexame 8 mg/day 4-7-77 15.3 463 18.3 
Metyrapone 750 mg x 6 4-8-77 29 15.8 
day #1 4-9-77 10.3 
day #2 4-10-77 134 15.0 
4-11-77 12.6 4.3 
Right Adrenalectomy 5-16-77 
9-20-77 82 6.0 157 
ACTH I.M. 40 units 11-20-77 
11-21-77 10.4 5.5 6.0 
11-23-77 4.4 2.4 
11-24-77 7,0 
ACTH I.M. 40 units 11-26-77 2.0 2.9 
11-27-77 10.4 2.2 
Off ACTH but while on 2-13-78 9 5 46 
replacement therapy 1-6-79 21.6 7.0 
2-14-79 34 
1-22-80 91 
* Dexamethasone 
tubular reabsorption calcium leading to hypercalciuria 
(11,12), and decreased bone formation and increased bone 
resorption (13,14). All these effects contribute to a net 
negative calcium balance that leads to osteoporosis and, in 
some patients, to nephrolithiasis. 
Both of our patients were referred initially for evaluation of 
severe osteoporosis and nephrolithiasis. The usual signs of 
hypercortisolism were minimal or absent, and the diag-
nosis was made during a routine screening for other causes 
of osteoporosis. Besides these two cases, five other patients 
have been reported (4,6,15,16) with skeletal symptoms as 
the major presenting feature of hypercortisolism (Table III). 
The duration of skeletal symptoms before the diagnosis of 
hypercortisolism was two to seven years. Two of the seven 
patients had nephrol i thiasis in addi t ion to severe os-
teoporosis, and the first patient was initially thought to have 
primary hyperparathyroidism (15). 
Adrenal pathology was available in five of the seven cases. 
The remaining two patients were thought clinically to have 
bilateral adrenal hyperplasia. Blackor brown pigmentation 
was found in three, but no mention was made in the other 
two. "Black adenoma" (or hyperplasia), previously thought 
to be nonfunctional, is now recognized as a distinct clinical 
entity which may be associated with either hypercortisol-
ism or aldosteronism (17,18). The deposition of pigment 
(black, brown, or blue) in the adrenal gland is believed to 
represent an " e x h a u s t i o n " or "wea r and tear" phe-
nomenon (19) that indicates a long-standing disease pro-
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TABLE II 
Endocrine Studies 
Case 2 
Control 
Control 
Dexame* 
Dexame 
Dexame 
Dexame 
Control 
Dexame 
Dexame 
Dexame 
Dexame 
2 mg/day 
2 mg/day 
8 mg/day 
8 mg/day 
2 mg/day 
2 mg/day 
8 mg/day 
8 mg/day 
Control 
Metyrapone 750 mg x 6 
day #1 
day #2 
Control 
Control 
Alpha 1-24 ACTH I.V 
0 min 
30 min 
60 min 
Proton beam irradiation 
of pituitary 
Plasma Urine 
Dexame 1 mg/overnight 
Dexame 1 mg/overnight 
Dexame 1 mg/overnight 
11-17-75 
11-18-75 
11-19-75 
11-20-75 
11-21-75 
11-22-75 
2-11-76 
2-12-76 
2-13-76 
2-14-76 
2-15-76 
2-16-76 
2-17-76 
2-18-76 
2-19-76 
2-20-76 
2-21-76 
4-13-76 
4-14-76 
4-15-76 
(basal) 
9-6-76 
9-7-76 
9-10-76 
10- 29-76 
11- 18-76 
12- 29-76 
3-17-77 
3- 23-77 
4- 18-77 
4-20-77 
6-8-77 
6-9-77 
Cortisol 
(Mg/dl) 
a.m. p.m. 
14.7 2.2 
ACTH 
(pg/ml) 
a.m. p.m. 
Free Cortisol 
(Mg/24hr) 
170 
166 
64 
32 
25 
13 
16.0 26.0 314 
11.5 
<2.0 
20.0 
16.0 
15.5 13.7 
23.0 
39.0 
54.0 
29.0 26.0 (after overnight 1 mg Dexame suppression) 
28.7 25.8 
17-OHCS 
(mg/24 hr) 
22 
23 
16 
;5 
9 
8 
10 
6 
Ca 
(mg/24 hr) 
333 
299 
140 
60 
17 1029 
140 150 553 
12.6 
7.3 
2.C 
2.0 
30.0 
18.0 
18.0 
15.3 
107 111 
• Dexamethasone 
cess. This would explain the milder symptoms and signs of 
hypercortisolism in patients presenting with skeletal man-
ifestations, as well as the frequent finding of pigmented 
adrenal glands. Apparently, the clinical effects of cortico-
steroid excess, as ofother endocrinopathies, vary with the 
rate of progression. Rapid progression, as in some patients 
with the ectopic ACTH syndrome, causes predominant 
electrolyte disturbance, whereas "normal" progression 
gives rise to classic Cushing's syndrome, and slow progres-
sion to predominant osteoporosis (Table IV). 
Physicians should always suspect hypercortisolism in pa-
tients with unexplained osteoporosis, especially when the 
loss of bone is more severe than would be expected for 
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T A B L E III 
Seven Patients with Hypercortisolism and Osteoporosis 
Durat ion of 
Skeletal Initial Clinical Adrenal 
Case/Age/Sex Presenting Feature Symptoms X-Ray Findings Diagnosis Pathology 
1/41/M (15) Back pain, loss of height 2 years Multiple rib and 
vertebra compression 
fractures 
Primary 
hyperparathyroidism 
Bilateral 
micronodular 
hyperplasia; 
pigment not 
mentioned 
2/19/M (6) Chronic back pain 2 years Vertebral 
compression 
fractures 
Idiopathic 
osteoporosis 
Micronodular 
adrenal disease 
with brown 
pigment 
3/23/F (6) Spontaneous rib 
fracture 
3 years Multiple rib fractures Idiopathic 
osteoporosis 
Micronodular 
adrenal disease 
with black 
pigment 
4/46/M (16) Right hip pain 7 years Multiple rib fractures, 
aseptic necrosis of 
femoral head 
Aseptic necrosis of 
femoral head 
Not available; 
hyperplasia by lab 
evidence 
5/64/F (4) Back pain, rib fractures, 
purpuric skin lesions 
2 years Multiple rib and 
vertebral 
compression 
fractures 
Metastatic medullary 
thyroid carcinoma 
Bilateral cortical 
hyperplasia; 
pigment not 
mentioned 
6/52/F 
(Case 1) 
Back pain, kidney 
stones 
2 years Healed fracture of 
right inferior pubic 
ramus 
Postmenopausal 
osteoporosis and 
nephrolithiasis 
Right adrenal 
black adenoma 
7/62/M 
(Case 2) 
Spontaneous rib 
fractures, kidney stones 
2 years Multiple fractures of 
ribs, vertebrae, pubic 
rami and acetabulum 
Idiopathic 
osteoporosis 
Not available; see 
text 
T A B L E IV 
Relationship Between Progression of the D isease and Clinical 
Manifestations in Patients with Hypercortisolism 
Progression Clinical Presentation Adrenal Pathology 
Rapid Hypokalemia Ectopic ACTH 
syndromes 
"Normal" Classic Cushing's "Usual" (adenoma 
or hyperplasia) 
Slow Osteoporosis and/or Pigmented (adenoma 
nephrolithiasis or hyperplasia) 
their age and sex. It is important to avoid delay in diag-
nosis, since osteoporosis in this disease is preventable but 
not reversible (2). Urine-free Cortisol is a more sensitive test 
than the plasma Cortisol, because it is an index of the 
integrated Cortisol secretion rate. This test should be ob-
tained routinely as a part ofthe evaluation of osteoporosis. 
Acknowledgments 
The authors thank Dr. James L. Males, Oklahoma City, Oklahoma, for 
performing and providing the investigations in Case 2; Dr. Wi l l iam H. 
Beierwaltes, Llniversity of Michigan, Ann Arbor, Michigan, for performing 
' " I Iodocholesterol adrenal scan in Case 1, J. Masterson and F. Hicks for 
secretarial assistance. 
We deeply appreciate the guidance, encouragement, and criticism of Dr. 
Parfitt, Henry Ford Hospi ta l , Detro i t , du r ing the preparat ion of the 
manuscript. 
136 
Cushing's Syndrome with Osteoporosis 
References 
1. Curtiss PH, Clark WS, Herndon CH. Vertebral fractures resulting from 
prolonged and corticotropin therapy JAMA 1954;156:467-69. 
2. lannaccone A, Gabrilove JL, Brahms SA, Softer LJ. Osteoporosis in 
Cushing's syndrome. Ann Intern Med 1960;52:570-87. 
3. Bahu RM, Battifora H, Shambaugh G. Functional black adenoma of 
the adrenal gland. Arch Pathol 1974;98:139-42. 
4. Rosenberg EM, Hahn TJ, Orth DN, Deftos LJ, Tanaka K. ACTH-
secreting medullary carcinoma of the thyroid presenting as severe 
idiopathic osteoporosis and senile purpura: Report of a case and 
review o f the literature. J Clin Endocrinol Metab 1978;47:255-62. 
5. Strickland AL, Underwood LE, Voina SJ, French FS, VanWyk JJ. 
Growth retardation in Cushing's syndrome. Am J Dis Child 1972; 
123:207-13. 
6. Ruder HJ, Loriaux DL, Lipsett MB. Severe osteopenia in young adults 
associated with Cushing's syndrome due to mcironodular adrenal 
disease. J Clin Endocrinol Metab 1974;39:1138-47. 
7. Hahn TJ, Boisseau VC, Avioli LV. Effect of chronic corticosteroid 
administration on diaphyseal and metaphyseal bone mass. J Clin 
Endocrinol Metab 1974;39:274-82. 
8. Fisher DE, Bickel W H . Corticosteroid-induced avascular necrosis. J 
Bone Joint Surg 1971;53A:859-73. 
9. Scholz DA, Sprague RG, Kernohan JW. Cardiovascular and renal 
c o m p l i c a t i o n s o f C u s h i n g ' s s y n d r o m e . N Engl J M e d 
1957;256:833-37. 
10. Hurxthal LM, O'Sullivan JB. Cushing's syndrome: Clinical differential 
diagnosis and complications. Ann Intern Med 1959;51:1-16. 
11. Wa jchenberg BL, V i rg i l i o GP, Kieffer J, Ursic S. Effect of dex-
amethasone on calcium metabolism and '"Ca kinetics in normal 
subjects. Acta Endocrinol 1969;61:173-92. 
12. Laake H. The action of corticosteroids on the renal reabsorption of 
calcium. Acta Endocrinol 1960;34:60-64. 
13. Riggs BL, Jowsey J, Kelly P. Quantitative microradiographic study of 
bone r e m o d e l i n g in C u s h i n g ' s s y n d r o m e . M e t a b o l i s m 
1966;15:773-80. 
14. Aloia JF, Roginsky M, Ellis K, Shukia K, Cohn S. Skeletal metabolism 
and body composition in Cushing's syndrome. ] Clin Endocrinol 
Metab 1974;39:981-85. 
15. Mellinger RC, Smith RW. Studies of the adrenal hyperfunction in two 
patients w i t h atypical Cushing's syndrome. J C l in Endocr inol 
1956;16:350-66. 
16. Pinhas S, Kaplinski N. Leiba S, Franki O. Aseptic necrosis of head of 
femur: Presenting manifestation in Cushing's disease. J Rheumatol 
1977;4:73-75. 
17. Tseng CH, Chang GKJ, Wong QY, Lin Jl. Cushing's syndrome and 
functioning adrenal black adenoma. South Med J 1978;71:1166-68. 
18. Caplan RH, Virata RL. Functional black adenoma of the adrenal 
cortex. Am J Clin Pathol 1974;62:97-103. 
19. Garret R, Ames RP Black-pigmented adenoma of the adrenal gland. 
Arch Pathol 1973;95:349-53. 
137 
